We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current ZTS market cap is 82.06B. The company's latest EPS is USD 5.1370 and P/E is 35.01.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 2B | 2.18B | 2.15B | 2.21B | 2.19B |
| Operating Income | 707M | 815M | 776M | 683M | 797M |
| Net Income | 552M | 671M | 596M | 525M | 599M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 6.26B | 6.68B | 7.78B | 8.08B | 8.54B |
| Operating Income | 1.97B | 2.22B | 2.73B | 2.88B | 2.98B |
| Net Income | 1.5B | 1.64B | 2.04B | 2.11B | 2.34B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 13.75B | 13.75B | 14.11B | 14.29B | 14.35B |
| Total Liabilities | 9.26B | 9.13B | 9.03B | 9.3B | 9.3B |
| Total Equity | 4.49B | 4.62B | 5.07B | 4.99B | 5.05B |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 11.55B | 13.61B | 13.9B | 14.93B | 14.29B |
| Total Liabilities | 8.84B | 9.84B | 9.36B | 10.52B | 9.3B |
| Total Equity | 2.71B | 3.77B | 4.54B | 4.4B | 4.99B |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 549M | 732M | 1.46B | 2.35B | 595M |
| Investing | -216M | -296M | -567M | -777M | -131M |
| Financing | -1.8B | -2.3B | -2.71B | -3.11B | -524M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | 1.8B | 2.13B | 2.21B | 1.91B | 2.35B |
| Investing | -504M | -572M | -458M | -883M | -777M |
| Financing | -951M | 123M | -1.86B | -904M | -3.11B |
| Market Cap | 82.06B |
| Price to Earnings Ratio | 35.01 |
| Price to Sales Ratio | 9.6 |
| Price to Cash Ratio | 40.21 |
| Price to Book Ratio | 16.44 |
| Dividend Yield | 0.93% |
| Shares Outstanding | 456.3M |
| Average Volume (1 week) | 1.76M |
| Average Volume (1 Month) | 1.86M |
| 52 Week Change | -5.02% |
| 52 Week High | 201.92 |
| 52 Week Low | 144.80 |
| Spread (Intraday) | 7.18 (3.92%) |
| Company Name | Zoetis Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.zoetis.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
